| Bioactivity | Dithio-CN03 is a compound with the highest neuroprotective efficacy. Dithio-CN03 fights the progression of retinitis pigmentosa (RP) by inhibiting the cGMP mediated signaling pathway and reducing photoreceptor cell death. Dithio-CN03 can be used in research into RP and other retinal degenerative diseases[1]. |
| Formula | C24H30BrN6O6PS |
| Molar Mass | 641.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Pérez O, et al. New Improved cGMP Analogues to Target Rod Photoreceptor Degeneration[J]. Journal of Medicinal Chemistry, 2024. |